We assumed that the specific modulations of the ratio between proapoptotic and antiapoptotic Bcl-2 family proteins in cancer cells treated with cisplatin/LA-12 and TRAIL may help to render mitochondria more susceptible to apoptotic signal transmitted from DRs via tBid. This evidence concerns the gene BCL2 and cancer.